Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open, Randomized, Multicenter, Randomized Phase II Trial Comparing the Combination of Cetuximab With Oxaliplatin/5-FU/FA Versus the Combination of Cetuximab With Irinotecan/5-FU/FA as Neoadjuvant Treatment in Patients With Non-Resectable Colorectal Liver Metastases

NCT00153998 is registered in ClinicalTrials.gov with Technische Universität Dresden as lead sponsor.

NCT NCT00153998
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00153998 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open, Randomized, Multicenter, Randomized Phase II Trial Comparing the Combination of Cetuximab With Oxaliplatin/5-FU/FA Versus the Combination of Cetuximab With Irinotecan/5-FU/FA as Neoadjuvant Treatment in Patients With Non-Resectable Colorectal Liver Metastases
Lead sponsor
Technische Universität Dresden
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2004
Completion date
Not reported
Enrollment
135 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer, liver metastases